Jade Biosciences
Price & Volume
Stats
See moreOpen | $22.11 |
Previous Close | $22.21 |
Day Range | $21.52-$22.55 |
52W Range | $6.56-$28 |
Market Cap | $1B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.63 |
News
See moreYahoo Finance • 3 hours ago
Jade Biosciences Announces First Participant Dosed in First-in-Human Phase 1 Clinical Trial of JADE201, a Novel Half-Life Extended Afucosylated Anti-BAFF Receptor Monoclonal Antibody
Yahoo Finance • 13 days ago
Why This Biotech Fund Added $7 Million to an Oncology Stock Up 120%
Yahoo Finance • 3 months ago
Jade Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Yahoo Finance • 5 months ago
Jade Biosciences Announces $45 Million Private Placement
About
CEO | Mr. Tom Frohlich |
CFO | Mr. Bradford D. Dahms Ph.D. |
Address | Building 23, Waltham, MA, United States, 02453 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 55 |